Beximco Pharmaceuticals acquiert 54,6% du capital de Sanofi Bangladesh Sanofi Bangladesh

Bredin Prat a conseillé Sanofi dans le cadre de la cession du contrôle de Sanofi Bangladesh à Beximco Pharmaceuticals. Dr. Kamal Hossain & Associates a conseillé…

This content is for members only.
Login Join Now

Author: Naoual Sadouqi

This content is for members only.
Login Join Now